Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells

Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells

US Patent 7736647 · Granted Jun 15, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multispecific antigens binding fragments and multspecific antibodies2025
Antibodies having specificity for CD38 and uses thereof2025
Multispecific antigens binding fragments and multispecific antibodies2024
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2023
Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therap2022
Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof2021
Monoclonal antibodies binding to the CD160 transmembrane isoform2021
Multispecific antigen binding fragments and multispecific antibodies derived the2020
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2020
Antagonists of IL-17 isoforms and their uses2019
Anti-CD160 specific antibodies for the treatment of eye disorders based on neoan2019
Antagonists of IL-17 isoforms and their uses2017